The intricate world of pharmaceutical research, particularly the demanding phases of clinical trials, stands at a pivotal juncture. Faced with…
Read More
Protecting innovation in a borderless pharma economy: The reality of globalized pharma innovation
The pharmaceutical industry, a cornerstone of global health and economic development, operates today within an increasingly interconnected and complex global…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
For decades, the pharmaceutical industry has grappled with the inherent inefficiencies of drug discovery, a process often likened to searching…
Read More
Blazing new paths for biotech
For the past several years, success has grown more elusive for American biotech firms, grappling with a confluence of shifting…
Read More
Boehringer Ingelheim eyes MASH as the next front for survodutide, a GLP-1/glucagon receptor dual agonist
For decades, fatty liver disease, and its more severe inflammatory progression known as metabolic dysfunction-associated steatohepatitis (MASH), remained largely overlooked…
Read MoreAmerican Diabetes Association Conference Sees Landmark GLP-1 Trial Results Amidst Unprecedented Controversy Over Researcher Removal
The annual national conference of the American Diabetes Association (ADA) this week served as a pivotal platform for unveiling cutting-edge…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a rapidly emerging biotech startup formerly known as Somite AI, has secured global rights to a clinical-stage Parkinson’s…
Read More
FDA Commissioner Marty Makary Resigns Amidst Mounting Pressure and Regulatory Turmoil
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, a departure precipitated by intense administrative pressure…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…
Read More
CNPV: A gamechanger for the pharma industry or simply more chaos?
The pharmaceutical industry finds itself at a pivotal juncture with the advent of the U.S. Food and Drug Administration’s (FDA)…
Read MoreYOU MAY HAVE MISSED
